• My Account
  • Language
    • English
    • Italian
logo
  • Home
  • Who We Are
  • What We Do
    • ARIYA, THE AI PLATFORM
    • BUSINESS INSIGHT
      • Business Intelligence
      • Market/Therapy Area Assessment
      • Competitive Intelligence
    • BUSINESS PLANNING
      • Forecasting
      • Patient Pathway
      • Portfolio Assessment
      • Key Account Management
      • Pricing Analytics
    • SCIENTIFIC SERVICES
      • Epidemiology Assessment
      • Patient Chart Review
      • HEOR
      • KOL Identification and Profiling
      • White Paper
      • Medical Writing
    • DIGITAL WINGMAN
  • How We Do It
    • CLIENTS
    • Careers
    • Blog
    • Find us
    • Resources
  • My Account
  • Language
    • English
    • Italian

Blog Metro Boxed

People going crazy over the grid metro style.

  • Show all
  • Uncategorized
  • Disease Awareness
  • Disruptive Technology
  • News Updates
  • Resources
  • Arts
  • Travel
  • Business
Disruptive Technology

March 29, 2023

How AI Can Help You Find the Right Key Opinion Leader (KOL)

Uncategorized

September 6, 2021

Modern age consulting: Wingman, your extended arm

Disruptive Technology

October 21, 2019

The Rising Need of Visualization Tools in The Pharmaceutical Industry

Disruptive Technology

October 17, 2019

The Role of Real-World Data (RWD) in Precision Medicine

Disruptive Technology

October 9, 2019

Personalized Healthcare in Switzerland

Disruptive Technology

September 23, 2019

Personalized Medicine: Revolutionizing Cancer Treatment

Resources

September 10, 2019

How patient pathways boost pharma businesses

News Updates

August 28, 2019

Real World Evidence: A Pharma-evolution

News Updates

July 5, 2019

4 Key Components of a Successful Forecasting Model

Disease Awareness

June 11, 2019

Gene Therapy — A Ray of Hope for Haemophilia A Patients

Disease AwarenessNews Updates

May 21, 2019

The role of registries in Haemophilia management

News Updates

March 1, 2019

Presenting the brand new identity of phamax

Disease Awareness

February 20, 2019

Perinatal Management of Haemophilia

Disease Awareness

February 20, 2019

Haemophilia Prophylaxis

News Updates

February 20, 2019

Why is Big Data Dominating Business?

Travel

March 25, 2017

Calm over the horizon

ArtsBusiness

March 22, 2017

Inspired by clouds

Business

March 20, 2017

Make it clean and simple

Add comment Cancel reply

© 2025 phamax – All rights reserved
Privacy Policy | About Cookies | Contact Us

Privacy Preference Center

Privacy Preferences

Find out more:

HEOR

Health technology assessments (HTA) to reimburse a new health technology typically encompass an economic analysis. Pharmaceutical manufacturers must demonstrate the clinical and economic evidences of products to gain market access and remain competitive. Economic evidence is often generated by evaluating both costs and outcomes to prove the efficiency of a product. phamax HEOR services generate relevant evidence for products to communicate their value to stakeholders.

phamax HEOR services include:

  • Systematic literature reviews and meta-analysis: Our systematic literature review services answer all the important questions on efficacy, safety, quality of life and resource use. We follow the PRISMA guidelines and work with clients to define the scope of project, submit the protocol, identify databases, and shortlist articles. We critically appraise relevant research and analyse data from studies to answer the clients’ research questions and also perform meta-analysis, when required
  • Patient Reported Outcomes (PRO)

phamax PRO studies provide unique insights into how a therapy can affect a patient. We design studies that enable clients to capture patient perspectives on a disease/treatment under different scenarios – clinical (e.g. cure, survival), humanistic (e.g. role performance, emotional status) and economical (e.g. expenses, saving)

  • Economic evaluations:

  • Cost-effectiveness analysis (CEA)
  • Cost-utility analysis (CUA)
  • Budget-impact analysis (BIA)
  • Burden of disease or Illness/Economic impact analysis

Our models estimate the costs and outcomes of interventions, and compare different interventions impacting the same health effects (usually measured as life years gained) and different health effects (usually measured as utility-based outcome units (QALYs)). HEOR models for economic evaluations are the new normal for favourable reimbursement decisions. Our services demonstrate the cost effectiveness of product vs. the competition to support reimbursement submissions and highlight the incremental effectiveness of products at multiple price points.

  • Synthesis of systematically-derived data for clinical and economic analyses
  • Support reimbursement decisions by evaluating the clinical and economic impact of products
  • Understand the impact of technologies in a real-life context and comprehend the needs and preferences of patients
  • Understand the quality of life aspects and measure the burden of the disease by incorporating all the costs associated with the disease/intervention
  • Evaluate the long-term effects (length and quality of life) of an intervention on health outcomes and ease the comparison of costs and outcomes of different interventions
  • Determine the impact of implementing or adopting a particular technology on a designated budget

Scientific Platform Development

The phamax scientific platform communicates a single vision for goals across multiple channels and stakeholders. phamax is a recognized leader in scientific communication platforms. We have presented original research, given invited presentations and conducted workshops at various scientific meetings. Our teams are extensively experienced in developing scientific platforms for almost any situation for de novo and top pharmaceutical companies.

  • Engage the relevant external stakeholders and leverage the ‘loyalists and enthusiasts’
  • Identify the engagement models to:

  • Address the gaps and resolve the issues due to unmet needs
  • Position organizations as the champions for change
  • Empower external stakeholders

  • Identify the potential scope for activities to:

  • Identify the potential opportunities/challenges (immediate and long-term)
  • Internally align for ‘quick responses’

  • Develop pragmatic action plans to realize benefits and:

  • Chalk out activity roadmaps
  • Institutionalize adherence to the activity roadmaps

  • Identify the feedback channels to:

  • Continually engage regional stakeholders
  • Provide opportunities to collaborate

  • Identify the continued outreach opportunities to facilitate:

  • Sustained engagement with the relevant stakeholders
  • Continued knowledge and experience dissemination
  • Plans to stay ahead of the competition

  • Understand the existing prescribing trends, unmet needs, and potential markets for products
  • Explore related health economic benefits
  • Continued professional development
  • Develop guidelines and management protocols/manuals
  • Enable and support decisions
  • Generate data wealth from the real world
  • Understand the target segments and geographic scopes
  • Leverage the existing resources, estimate the resources required and plan effective resource utilization

Sustain and implement the best protocols and guidelines in routine practice

Patient Chart Review

The phamax real-world evidence solutions empower the RWE strategies of companies with a deeper understanding of therapeutic landscapes and market-shaping dynamics. The phamax patient chart review services give pharmaceutical companies advanced inputs on the existing standards of care, healthcare resource utilization and patient-reported outcomes.

The phamax RWE division provides supporting evidence for a broad range of therapeutic areas. The phamax chart review services are widely applied in many healthcare-based disciplines such as epidemiology, quality assessment, professional education and residency training, inpatient care and clinical research.

Our patient chart review services use:

  • Subject matter experts to deliver unique, intelligent RWE strategies to increase clinical research efficiencies
  • In-house statistical teams to enhance value stories and provide compelling evidence
  • Rich in-house capabilities to review and understand product and disease dynamics

  • Transform complex transactional data into insights for drug utilization, prescribing trends, cost-of-care trends and health outcomes
  • Determine market niches, product usage dynamics and untapped marketing opportunities
  • Gain real-time insights for informed business decisions to:

  • Identify gaps in care
  • Stratify patient risks
  • Engage stakeholders
  • Create physician-patient interfaces
  • Manage supply chains
  • Extract hidden evidence

  • Gain valuable information for direct subsequent prospective studies

Key Account Management

phamax reviews the existing KAM structure and analyses the account-level data for robustness/integrity to identify the gaps, provide appropriate solutions based on customer needs and develop KAM as a mind-set. We help our clients in developing the best-in- class strategy, customized account-level services, optimal KAM team structure and thereby increased ROIs.

Our KAM framework utilizes:

  • Qualitative research to design the KAM working details, local KAM principles and guidelines, KAM vision, objectives, roles and responsibilities in collaboration with the client team
  • Quantitative research to review the current account segmentation, KAM team workload and performance

We develop a prioritized list of recommendations and a corresponding action plan based on the qualitative and quantitative research.

  • Understand the account potential, current penetration levels and value proposition
  • Prioritize the list of target accounts (e.g. tier 1, 2 and 3)
  • Optimal KAM team structure
  • Individual account value chain
  • Track account performances and relative moments (e.g. on the 3×3 grid)
  • Manage the challenges effectively while implementing the KAM strategy

Patient Journey Modelling

Discover the unattended patient segments and access untapped markets by visualizing patient movements. Understand treatment perceptions and physician preferences via the phamax patient journey models.

The phamax patient journey offering is a proven, proprietary and solution-oriented three-pronged approach tested and validated across multiple therapy areas and companies.

A – Analyze the real-world scenarios to develop a detailed patient journey to identify hidden patient segments and barriers to access /growth drivers

E– Review the drivers and barriers with all the stakeholders to successfully expand to new segments. Prioritize the segments and develop an action plan

A – Unlock growth potential by strategically implementing the business plan at the local levels with insights from the patient journey

  • Unlock growth opportunities with access to unattended patients
  • Paradigm shift in marketing resource allocation and deployment
  • Greater commercialization impact through targeted approaches
  • Develop robust brand plans

Whitepaper

The phamax white paper services generate authoritative and compelling reports for information on complex issues in therapeutic areas of focus. phamax generates credible information by combining expert knowledge and research to share relevant information on customers, potential customer bases and the latest industry trends.

phamax offers unparalleled commitment and quality to develop influential vantage point white papers which garner useful information about new products, markets or ways to re-hash obsolete data. We empower companies with the confidence to broadcast their products and solutions worldwide with the trustworthy information we create.

Our white paper services use:

  • Extensive experience in research
  • An envious panel of doctors doing primary and secondary research

  • Generate leads, build mindshare and open doors to new sales opportunities
  • Showcase expertise and build brand image
  • Educate the audience on newer perspectives in the industry

Ad-boards

Collective consensus – by engaging stakeholders in deliberative discussions, integrating ideas from structured dialogues, and with sustained stakeholder engagement processes – can pave the way to better solutions.

The phamax ad-board services provide independent strategic advice to steer companies on the right track and define the best development path for products. phamax addresses multifaceted challenges by tailoring its associations as per each organization’s objectives, market and culture by merging best research practices with hands-on support from its experts.

The phamax ad-board services develop an advisory board, expert group or panel as per the needs of its massive stakeholder network to guide in the development phase, therapeutic area, regulatory review preparation etc. The services:

  • Engage stakeholders before and after meetings for more customer touchpoints
  • Envision an orchestrated, cross-country approach with expert group members from various countries
  • Perform end-to-end project management with preparations, meetings and stakeholder management
  • Facilitate both qualitative and focus group discussion meetings, and promote peer-to-peer stakeholder engagement
  • Represent the working team as an external voice
  • Handle both client and stakeholder communications

  • Guidance on clinical trial protocols
  • Guidance on unmet medical needs to drive future clinical strategies
  • Actionable deliverables to foster positive relationships with prominent scientific community members
  • Relevant and reliable educational and promotional content

KOL

phamax identifies KOLs via need assessment tools to offer customized solutions. Our robust approach identifies, prioritizes, segments and validates KOLs with in-depth secondary research. We combine qualitative and quantitative research as per various KOL activities – publications, congress presentations, clinical trials, guidelines, committees, editorial boards, company affiliations, regulatory bodies, associations and advocacy groups. We further profile the KOLs – demographics, memberships and roles in societies, abstracts of major publications, presentations and involvement in clinical trials.

phamax offers multiple KOL services:

  • Identification and profiling of KOLs/KEEs
  • Identification and profiling of rising stars
  • Influence mapping and network analysis of KOLs/KEEs
  • Progression analysis of KOLs/KEEs
  • Databases in MS Excel, MS Access and CRM applications

Our KOL services:

  • Deploy In-house physician teams for qualitative insights to identify and profile KOLs
  • Use different tools and advanced analytic techniques to gather data from publications, clinical trials and conferences
  • Have a robust methodology to rank the KOLs/KEEs as per needs
  • Do an exclusive name-matching analysis to identify unique physicians
  • Map global and local KOLs/KEEs as per their involvement in activities
  • Leverage flexible teams with rich experience in multiple therapeutic categories
  • Track activities and update the databases regularly
  • Comply to country regulations and guidelines

  • Effective product strategies by engaging the right KOLs
  • Brand marketing and promotional activities with the KOLs
  • New product research areas
  • Phase IV outcomes research
  • Ready-to to-use KOLs data which to saves time and cost

Pricing Analytics

We determine the optimal price range for products by assessing the relevant internal and external factors. We support pharmaceutical companies in effective pricing decisions using analytical modeling to decrypt the real-world complexities. 

Our price mapping services:

  • Validate a product’s price based on its clinical profile, PLC stage, competitive landscape, and performance
  • Identify a product’s optimal price range by benchmarking against suitable historical analogs
  • Develop a market reference map based on the processes and regulations impacting the pricing decisions
  • Build a referencing model to quantify the impact of price changes elsewhere and adapt accordingly

  • Insights for the ideal product price in the market
  • Unambiguous pricing decisions by assessing external events
  • Maximized commercial success by optimizing a product’s geographic launch sequence

Entry and Expansion Strategy

Make the critical decision of ‘launch or license’ with our entry and expansion support. Our team supports all pharmaceutical commercialization activities – shaping your market entry or expansion strategies with relevant market insights or launching your products in new markets. The phamax comprehensive commercial model evaluation approach helps you formulate robust market entry strategies.

Our local team of experts not only design but implement the strategies. The phamax range of services include:

  • Market attractiveness: Assess the market size and growth, and understand the market evolution with the drivers and barriers
  • Market access landscape: Identify the relevant pricing and reimbursement scenarios
  • Product potential assessment: Forecast the product sales in different scenarios
  • Commercial model evaluation: Develop the commercial models for own launches (in-house vs outsourced functions), out-licenses, co-promotions, co-marketing or complete divestments

  • Focused and targeted strategies to optimize resources
  • Realistic view of markets and product potential
  • Solutions for local market access challenges
  • Flexibility to choose the best-fit commercial models
  • Execution speed with minimal risks

Forecasting

Foresee market evolutions and product opportunities with the phamax forecasting services. Plan your business better by predicting overall revenues, understanding physician preferences and comprehending relevant market trends with our robust forecast models.

The phamax suite of forecasting services is either custom built as per your needs or comes in a ready-to-use format.

Our forecasting services use:

  • Rich inhouse capabilities to review and understand disease dynamics
  • Credible sources and well-documented assumptions
  • Inhouse uptake curves developed over a decade with 80+ launches
  • A flexible approach to adapt to the account/country/region/global levels
  • Multiple statistical techniques – Regression, ARIMA, ARMA, moving averages and simulation

  • Realistic view of the market and product potential
  • Clearer view of the impacts of changing market environments
  • Flexibility to choose the right one from multiple scenarios
  • Quantify future risks
  • Investment decisions to maximize product growth prospects

Regulatory Assessment

Our services help companies manage risks and unlock value by engaging effectively with regulators, policymakers, and other external stakeholders. phamax assesses commercial, clinical and market-specific regulatory factors for crucial insights on market dynamics and evolution vital to address payer expectations and secure favorable reimbursement status.

The phamax regulatory assessment uses three customizable dimensions:

  • Research to answer key intelligence questions (KIQs)
  • Collaboration with local regulatory stakeholders to address information gaps
  • The phamax scientific network to refine the insights

We simplify reporting processes, making regulatory filings less demanding. We provide country-specific regulatory landscape reports using the phamax scientific network with inputs from the local regulatory systems and stakeholders. Our solutions help companies comply with the local, regional and global regulatory requirements impacting products.

The phamax regulatory services:

  • Identify the regulatory requirements, and the market and customer drivers
  • Develop regulatory strategies and submissions
  • Help to implement compliance assurance processes
  • Provide direct access to on-call consulting support
  • Provide regulatory and research Q&A style support
  • Provide real-time information change notices (ICNs) on important changes
  • Substantiate waiver requests and read-across arguments
  • Provide product safety and efficacy evaluations
  • Provide third-party technical liaisons

– Understand the regulatory landscape to answer the KIQs on:

  • Pricing systems
  • Pricing and reimbursement processes
  • Roles and responsibilities of regulatory authorities
  • Recent case studies
  • Health economic evidence
  • Accessibility and affordability

– The realistic view of the market and product potential as per the core regulatory assessment principles
– Understand the impact of the changing market environment on the ever-changing regulatory guidelines
– Choose the right scenario from multiple options

Epidemiology Assessment

Epidemiological assessment identifies the relations between the needs and demands in the expansion of pharmaceutical and biological products. The phamax epidemiology assessment services help understand the market potential and identify the target patient segments. phamax develops an in-depth understanding of the disease landscape with scientifically-validated epidemiological analysis and forecast models.

phamax does an in-depth epidemiological analysis of therapeutic areas with primary and secondary research, real-world data and therapy-area expertise. Our scientific team includes experienced pharmaco-epidemiologists, physicians and biostatisticians. The team brings a broad range of scientific and operational experience while building forecasting models to accurately predict various epidemiological parameters such as incidence, prevalence, mortality, diagnosed population, treatment population, disease staging, risk-factors, related costs and medical management by age groups and sex. Our transparent and validated forecast models evaluating epidemiological transition and geographical extrapolation benefit global coverage.

The phamax epidemiological assessment services include:

  • Burden illness analysis
  • Disease prevalence and incidence analysis
  • Retrospective patient chart reviews
  • Longitudinal medical event database analysis
  • Medical chart abstraction
  • Pharma economic modeling
  • Survey research (patient and physician reviews)
  • Systematic literature reviews
  • Targeted literature reviews
  • Clinical practices
  • Patient pathways
  • Patient segmentation
  • Assessment of unmet needs
  • Disease-specific databases

  • Understand the complete disease landscape and global market sizes with real-world data
  • Benchmark forecasts with the total potential and addressable market data
  • Identify the growth opportunities and understand how populations change over time
  • Estimate the drug-treated populations with additional insights from therapeutic experts and primary market research

Medical Writing

phamax offers scientific writing services across the entire clinical research spectrum and is an expert in publications and medical communications services for global clients across all geographies.

Our team comprises writers with advanced degrees in medicine and other branches of life sciences. We have published various scientific publications in esteemed international journals. We have a wide range of research and clinical experience in multiple therapeutic areas like cardiovascular, medical devices, endocrinology, gastroenterology, hematology, oncology, orthopedics, respiratory, rheumatology, and urology.

The phamax medical writing services include a wide range of scientific and medical documentation ranging from manuscript writing for various research studies to regulatory submissions and medical communications documents such as:

  • Concept notes
  • Risk management plans (RMPs)
  • Clinical study reports (phase I-IV)
  • Systematic reviews
  • Protocols and amendments
  • Investigator brochures and updates
  • Manuscripts
  • Abstracts, slides and poster presentations
  • Medical marketing texts
  • White papers
  • Regulatory policy-shaping presentations

  • Works independently yet collaboratively
  • Produces high-quality documents with exceptional clarity, accuracy, and consistency
  • Proactively maintains accurate writing and delivery timelines
  • Anticipates the potential regulatory and publishing roadblocks

Portofolio Assessment

We maximize returns from mature products by identifying the optimal resource allocation and portfolio strategy. We identify the most attractive products for strategic focus and less attractive products for divestment with our extensive experience and comprehensive framework.

Our portfolio evaluation services:

  • Unbiasedly assess the complete product portfolio in line with the overall company and franchise objectives
  • Holistically evaluate the portfolio based on the relative attractiveness of the product, company, and market
  • Clearly guide on the product-portfolio fit and optimal strategic options – invest, status quo and divest
  • Deploy our extensive experience of 50+ projects with proven commercial benefits

  • Higher RoI with lower portfolio costs, optimized investments, and increased profitability
  • A streamlined portfolio focused on the high potential products
  • Identify the opportunities from the global portfolio to strengthen the existing country portfolios
  • Higher returns from the low potential and non-strategic products via collaboration with suitable external partners

Market Assessment

phamax offers a 360⁰ view of the competitor landscape with clinical, commercial and market access evaluations including, but not limited to, market drivers, existing and future therapies, unmet needs, disease burdens, and product potential. The phamax framework integrates clinical and commercial outputs to provide an in-depth understanding of market opportunities.

phamax offers a structured approach to understand and define the market opportunities as per needs:

  • The analysis of clinical factors for:

  1. Disease outlooks
  2. Epidemiology trends
  3. Treatment patterns
  4. Economic burden

  • The analysis of market factors for:

  1. Market potential
  2. Key market segments
  3. Competition
  4. Pricing and reimbursement
  5. Market dynamics
  6. Customer analysis

Our in-house clinical and commercial teams collect the data from reliable sources and rapidly analyze it for market insights and our investigative approach offers complete market/product assessments and capitalizes on the future opportunities for product development

  • A clear understanding of the markets and their drivers
  • Refined R&D strategies to focus on future market needs
  • Optimized R&D investments
  • Optimal resource utilization
  • A set of action points to leverage opportunities

Business Intelligence

Manage your business effectively with the phamax range of business intelligence services

  • Identify the KPIs for your business (Lead and Lag)
  • Collect, analyze and visualize the KPIs
  • Track the KPIs regularly for corrective actions

Our solution experts have extensive experience in designing, building and maintaining tailor-made dashboards. The highly flexible models adapt to your dynamic business needs and supply what you need, when you need it, the way you need it.

 

  • Easy and quick to update data
  • Real time data refresh
  • On-the-go access
  • Uniform view across users
  • Smart data visualizations
  • User-friendly navigation
  • Time savings as no need to communicate with others for data collection/update

Competitive Intelligence

We transform disaggregated information on markets and competitors into actionable insights. We combine secondary and primary research to derive information as per project objectives and scope. Our team continuously tracks the key parameters, provides regular updates (monthly/quarterly/half-yearly), develops key intelligence questions, and builds customized reports to meet specific requirements.

  • Sustained competitive advantage and growth
  • Strengths/Weaknesses of key competitor products to define the market or product strategies
  • Continuous insights on opportunities and threats
  • New technologies for business models

phamax’s structured and comprehensive CI package supports pharma companies in effective strategic, tactical and operational decisions to:

  • Track competition – who they are, what they do, how they think, where they want to be, and their strengths and weakness
  • Anticipate environmental changes, emerging threats, and opportunities in time to respond strategically
  • Uncover the latest trends driving the pharmaceutical industry
  • Profile various publicly available data sources for different types of information for easy and fast access
  • Develop reports with relevant information and update these regularly
  • Summarize financial facts
  • Our framework identifies relationships among various parameters and their impact on each other for vital insights

Thanks

Thanks for sending your information, we will contact you soon